Liver Transplantation for Pediatric Liver Cancer
Autor: | Louis Rapkin, Jean de Ville de Goyet, Sarangarajan Ranganathan, Vinayak Rohan, Sameh S. Tadros, Rakesh Sindhi, Andrew Bukowinski |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Oncology
Cancer Research medicine.medical_specialty Hepatoblastoma medicine.medical_treatment Review Liver transplantation chemotherapy lcsh:RC254-282 liver cancer 03 medical and health sciences 0302 clinical medicine Internal medicine Medicine Chemotherapy liver transplantation business.industry pre-text hepatocellular carcinoma Total Hepatectomy hepatoblastoma medicine.disease liver sarcoma lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens pediatric 030220 oncology & carcinogenesis Hepatocellular carcinoma histopathology 030211 gastroenterology & hepatology Histopathology Embryonal rhabdomyosarcoma business Liver cancer neuroendocrine tumor |
Zdroj: | Cancers, Vol 12, Iss 3, p 720 (2020) Cancers |
ISSN: | 2072-6694 |
Popis: | Unresectable hepatocellular carcinoma (HCC) was first removed successfully with total hepatectomy and liver transplantation (LT) in a child over five decades ago. Since then, children with unresectable liver cancer have benefitted greatly from LT and a confluence of several equally important endeavors. Regional and trans-continental collaborations have accelerated the development and standardization of chemotherapy regimens, which provide disease control to enable LT, and also serve as a test of unresectability. In the process, tumor histology, imaging protocols, and tumor staging have also matured to better assess response and LT candidacy. Significant trends include a steady increase in the incidence of and use of LT for hepatoblastoma, and a significant improvement in survival after LT for HCC with each decade. Although LT is curative for most unresectable primary liver sarcomas, such as embryonal sarcoma, the malignant rhabdoid tumor appears relapse-prone despite chemotherapy and LT. Pediatric liver tumors remain rare, and diagnostic uncertainty in some settings can potentially delay treatment or lead to the selection of less effective chemotherapy. We review the current knowledge relevant to diagnosis, LT candidacy, and post-transplant outcomes for these tumors, emphasizing recent observations made from large registries or larger series. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |